Faes Farma, a Madrid drugmaker, will establish a JV with China's Eddingpharm, a drug in-licensing company, to market Faes' products in China. Initially, the JV will commercialize four of Faes' offerings, with more to follow. Although the drugs were not specified, the portfolio presumably includes bilastine, a patent-protected non-sedating H1-antihistamine for allergic rhinitis and hives, which Faes markets under the name Bilaxten.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
